Down Risk 2nd Trimester (Triple Test)

Down’s Syndrome Risk Assessment – 2nd Trimester Screening

The Down’s Risk: 2nd Trimester Screening is a specialized maternal blood test designed to assess the risk of Down’s syndrome (Trisomy 21) and other chromosomal abnormalities during the second trimester of pregnancy. This test is performed between 14 to 19 weeks + 6 days of gestation and helps in identifying potential genetic conditions, allowing for early medical guidance and informed decision-making.

Tests Included in the Package:

1. Alpha-Fetoprotein (AFP) – A protein produced by the fetus, AFP levels help detect neural tube defects and can also be an indicator of chromosomal abnormalities.
2. Human Chorionic Gonadotropin (HCG) – A key pregnancy hormone, abnormal HCG levels can indicate an increased risk of Down’s syndrome or other fetal health concerns.
3. Unconjugated Estriol (uE3) – A type of estrogen produced by the placenta and fetus. Low levels of estriol may be associated with Down’s syndrome and other genetic conditions.

Why Choose This Test?

• Second Trimester Screening for Down’s Syndrome – Helps in assessing the risk of Trisomy 21 and other chromosomal disorders.
• Non-Invasive & Safe – A simple maternal blood test with no risk to the mother or baby.
• Essential for Pregnancy Monitoring – Provides additional risk assessment beyond the first-trimester screening.
• Accurate & Reliable Results – Conducted using advanced laboratory techniques to provide a precise evaluation.
• Optimal Testing Window – Performed between 14 to 19 weeks + 6 days for the most reliable assessment.

Who Should Take This Test?

• Pregnant women between 14 to 19 weeks + 6 days who missed the first-trimester screening.
• Women with a family history of chromosomal abnormalities.
• Expecting mothers over 35, as the risk of genetic conditions increases with maternal age.
• Those advised by their healthcare provider for further risk assessment.